The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Quantitative immunohistochemical (IHC) assessment of ataxia-telangiectasia mutated (ATM) in estrogen receptor (ER) negative early breast cancer (BC).
Patricia Tang
No relevant relationships to disclose
Alexander C. Klimowicz
No relevant relationships to disclose
Gregory Russell Pond
No relevant relationships to disclose
Daniel Yick Chin Heng
No relevant relationships to disclose
Marc A. Webster
No relevant relationships to disclose
Anthony M. Magliocco
No relevant relationships to disclose
D. Gwyn Bebb
No relevant relationships to disclose